2nd Circ. Told To Not Expand Antitrust Patent Fraud Standing
By Bryan Koenig · November 4, 2026, 6:53 PM EST
A pharmaceutical industry trade group has backed Bristol-Myers Squibb and its Celgene subsidiary in the Second Circuit, warning that health plans asking the appeals court to reinstate a proposed class action against...
To view the full article, register now.